Pyoderma gangrenosum in an infant: Case report;Pioderma gangrenoso em lactente - Relato de caso

Dermatology Online Journal

Volumn 18, Issue 7, 2012, Pages

  Medeiros, Camila Colombari ^a   Colombari, Milena Lacerda ^a   Nassif, Priscila Wolf ^a   Gurgel, Ana Cristina ^a   Nassif, Aissar Eduardo ^a  

^a Uninga Faculty   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE; DERMATOLOGICAL AGENT;

ARTICLE; CASE REPORT; FOLLOW UP; HUMAN; HUMAN TISSUE; INFANT; LEG ULCER; PYODERMA GANGRENOSUM; TREATMENT DURATION; TREATMENT RESPONSE; ULCER HEALING; MALE; PATHOLOGY; TREATMENT OUTCOME;

DERMATOLOGIC AGENTS; HUMANS; INFANT; MALE; PREDNISONE; PYODERMA GANGRENOSUM; TREATMENT OUTCOME;

EID: 84864023285     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB Jr, White WL, Callen JP. Pyoderma gangrenosum: a comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000;79(1):37-46.
2. Crowson AN, Mihm MC Jr, Magro C. Pyoderma gangrenosum: a review. J Cutan Pathol. 2003;30:97-107.
3. Wollina U. Pyoderma gangrenosum-a review. Orphanet Journal of Rare Diseases. 2007; 19(2): 1-8.
4. Su WPD, Davis MD, Weenig RH, et al.; "Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria", The International Journal of Dermatoloy; 2004; Vol. 43; 790-800;
5. Trost LB, McDonnell JK. Important cutaneous manifestations of inflammatory bowel disease. Postgrad Med J. 2005 Sep;81(959):580-5.
6. Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G. Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol. 2009 Sep;23(9):1008-17.
7. Graham JA, Hansen KK, Rabinowitz LG, Esterly NB. Pyoderma Gaegrenosum in Infants and Children. Pediatric Dermatology. 1994; 11(1): 10-7.
8. East-Innis A, Desnoes R, Thame K, Shirley S, Gilbert D. Pyoderma gangrenosum associated with osteomyelitis in a paediatric patient: a case report. West Indian Med J. 2005 Jun;54(3):207-9.
9. Fonder MA, Cummins DL, Ehst BD, Anhalt GJ, Meyerle JH. Adalimumab therapy for recalcitrant pyoderma gangrenosum. J Burns Wounds. 2006 Nov 20;5:e8.
10. Weenig RH, Davis MD, Dahl PR, Su WP. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med. 2002 Oct 31;347(18):1412-8.
11. Trent JT, Kirsner RS. Diagnosing pyoderma gangrenosum. Adv Skin Wound Care. 2001 May-Jun;14(3):151-3.
12. Thami GP, Kaur S, Punia RS, Kanwart AJ. Superficial granulomatous pyoderma: an idiopathic granulomatous cutaneous ulceration. J Eur Acad Dermatol Venereol. 2002 Mar;16(2):159-61.
13. Mani V. Pyoderma gangrenosum. Int J Low Extrem Wounds. 2002 Mar;1(1):43-8.
14. Dourmishev AL, Miteva I, Schwartz RA. Pyoderma gangrenosum in childhood. Cutis. 1996 Oct;58(4):257-62.
15. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology. 1991 Jun;100(6):1590-6.
16. Terjung B, Spengler U, Sauerbruch T, Worman HJ. "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology. 2000 Aug;119(2):310-22.
17. Kim FS, Pandya AG. The use of etanercept in the treatment of peristomal pyoderma gangrenosum. Clin Exp Dermatol. 2012 Jun;37(4):442-3.
18. Del Giacco SR, Firinu D, Lorrai MM, Serusi L, Meleddu R, Barca MP, Peralta M, Manconi PE. Idiopathic Pyoderma Gangrenosum: Successful Resolution with Infliximab Therapy and Pro-inflammatory Cytokines Assessment. Acta Derm Venereol. 2012 Mar; 92:1-3.